Welcome to EverybodyWiki 😃 ! Nuvola apps kgpg.png Log in or ➕👤 create an account to improve, watchlist or create an article like a 🏭 company page or a 👨👩 bio (yours ?)...

Balaji Srinivasan

From EverybodyWiki Bios & Wiki


Balaji Srinivasan
Balaji Srinivasan.png Balaji Srinivasan.png
Srinivasan in 2017
Born1979/1980
🏳️ Nationality
💼 Occupation
  • Former CTO of Coinbase
  • Former general partner at Andreessen Horowitz

Balaji Srinivasan (born 1979/1980)[1] is the former chief technology officer (CTO) of Coinbase, a former general partner at Andreessen Horowitz,[2] and an angel investor.

Early life and education[edit]

Srinivasan grew up on Long Island, in Plainview, New York.[3] He received BS, MS, and PhD degrees in Electrical Engineering and an MS in Chemical Engineering from Stanford University.[citation needed]

Career[edit]

In 2007, Srinivasan co-founded genetic testing company Counsyl, which provided tests to prospective parents to screen for Mendelian diseases.[1][2][4] Counsyl was acquired by Myriad Genetics for $375 million.[5][6]

In 2013, Srinivasan joined Andreessen Horowitz as a general partner.[7]

In April 2014, he co-founded Teleport, a search engine for digital nomads. Teleport was acquired by Topia in 2017.[8][9]

In 2013, Srinivasan co-founded 21.co, a Bitcoin mining startup that failed as a bitcoin mining business[10][non-primary source needed] but pivoted to become Earn.com, which allowed senders to pay users in digital currency to reply to emails.[1] Earn.com was acquired by digital currency exchange company Coinbase in April 2018 for over $100 million.[11][12] After Coinbase purchased Earn.com, it became Coinbase Earn and Srinivasan became Coinbase’s first CTO.[1][13][14] He left the company in 2019.[15]

He is an early investor in cryptocurrencies, including Bitcoin and Ethereum, as well as an angel investor for technology companies, including Benchling,[16] Dapper Labs,[17] Golden,[18] Omada Health,[19] Roam Research,[20] and Soylent.[21]

Public profile[edit]

MIT Technology Review named Srinivasan on its list of "Innovators Under 35".[4] In 2018, Fortune ranked him 26th on its "The Ledger 40 Under 40" list.[1]

In 2013, Srinivasan gave a talk at Y Combinator's Startup School titled "Silicon Valley's Ultimate Exit" and published "Software Is Reorganizing the World"[22] in Wired, which advocated for the technology industry to digitally exit the United States and move abroad. The talk was received positively by Reason,[23] Wired,[24] and Bloomberg News,[25] but was criticized by The New York Times[26] and The Wall Street Journal.[27]

In 2013, after TechCrunch published an article exploring links between Silicon Valley tech leaders and the Dark Enlightenment movement that mentioned this speech,[28] Srinivasan suggested doxing reporters who bring these links to the attention of the public. In an email to Curtis Yarvin, he wrote, "If things get hot, it may be interesting to sic the Dark Enlightenment audience on a single vulnerable hostile reporter to dox them and turn them inside out with hostile reporting sent to *their* advertisers/friends/contacts.”[29][30]

In 2017, the Trump Administration reportedly considered Srinivasan, as well as former HHS official Jim O'Neill, for appointment to FDA Commissioner.[31][32][33][34][35][36] While being considered for the appointment, Srinivasan deleted all of his tweets including ones in which he criticized the FDA.[37]

In 2021, Srinivasanl donated $50,000 in cryptocurrency to COVID relief in India during a resurgence of the COVID-19 pandemic. On Twitter, he pledged to donate another $50 for every time his post was retweeted, up to $100,000.[38][39][40]

References[edit]

  1. 1.0 1.1 1.2 1.3 1.4 "Balaji Srinivasan". Fortune. 2018. Archived from the original on 2021-01-12. Retrieved 2021-02-06. Unknown parameter |url-status= ignored (help)
  2. 2.0 2.1 Kafka, Peter (2017-01-14). "Balaji Srinivasan, who may run the FDA for Trump, hates the FDA. But Silicon Valley likes Srinivasan". Vox. Archived from the original on 2021-01-31. Retrieved 2021-02-06. Unknown parameter |url-status= ignored (help)
  3. Varadarajan, Tunku (22 September 2017). "The Blockchain Is the Internet of Money". Wall Street Journal.
  4. 4.0 4.1 "Balaji Srinivasan". MIT Technology Review. 2013. Archived from the original on 2021-02-06. Retrieved 2021-02-06. Unknown parameter |url-status= ignored (help)
  5. "Myriad Genetics Signs Definitive Agreement to Acquire Counsyl, Inc. | Myriad Genetics, Inc". investor.myriad.com. Retrieved 2021-04-30.
  6. "Myriad Genetics to Acquire Counsyl for $375M". Genomeweb. 2018-05-29. Retrieved 2021-04-30.
  7. Gannes, Liz (2013-12-10). "Balaji Srinivasan Joins Andreessen Horowitz as General Partner". Wall Street Journal. ISSN 0099-9660. Retrieved 2021-04-29.
  8. Cutler, Kim-Mai (2014-05-19). "Andreessen-Incubated Teleport Aims To Make Location Irrelevant For Mobile Workers". TechCrunch. Archived from the original on 2015-03-01. Retrieved 2016-08-04. Unknown parameter |url-status= ignored (help)
  9. Hankewitz, Sten (2017-04-03). "Estonian startup Teleport acquired by MOVE Guides". Estonian World. Archived from the original on 2019-03-16. Retrieved 2021-02-06. Unknown parameter |url-status= ignored (help)
  10. Srinivasan, Balaji S. (2018-04-16). "The Turnaround". Medium. Retrieved 2021-04-30.
  11. Rooney, Kate (2018-04-16). "Bitcoin exchange Coinbase buys Earn.com for a reported $100M and adds key executive". CNBC. Retrieved 2021-04-24.
  12. "Coinbase Acquires Earn.com". Wall Street Journal. 2018-04-17. ISSN 0099-9660. Retrieved 2021-04-29.
  13. Russell, Jon (2019-05-04). "Coinbase loses its first CTO after just one year in the job". TechCrunch. Archived from the original on 2019-11-30. Retrieved 2021-02-06. Unknown parameter |url-status= ignored (help)
  14. Armstrong, Brian (2018-04-16). "Welcome Balaji Srinivasan, Coinbase's new Chief Technology Officer". Medium. Retrieved 2021-04-23.
  15. Russell, Jon (4 May 2019). "Coinbase loses its first CTO after just one year in the job". TechCrunch.
  16. "Benchling wants to become the Salesforce of biotech". Fortune. Retrieved 2021-04-29.
  17. "CryptoKitties blockchain sensation raises $12 million". VentureBeat. 2018-03-20. Retrieved 2021-04-29.
  18. "Golden raises $14.5m Series A led by a16z, closes $1m US Air Force contract, and Marc Andreessen joins board". Golden Blog. 2020-09-30. Retrieved 2021-04-29.
  19. "Omada Health Raises $23M Series B Led By Andreessen Horowitz For Digital Health That Actually Works". TechCrunch. Retrieved 2021-04-29.
  20. "A $200 Million Seed Valuation for Roam Shows Investor Frenzy for Note-Taking Apps". The Information. Retrieved 2021-04-29.
  21. "Soylent, Created by CoE Alum, Raises $1.5 Million in Seed Funding". Georgia Tech College of Engineering. Retrieved 2021-04-29.
  22. "Software Is Reorganizing the World". Wired. ISSN 1059-1028. Retrieved 2021-04-30.
  23. "Tech Should Make It Easier To Escape Government Control, Says Startup Veteran Balaji Srinivasan". Reason.com. 2013-10-30. Retrieved 2021-04-30.
  24. "Silicon Valley's Elite Don't Want to Secede. They Just Want to Stay on Top". Wired. ISSN 1059-1028. Retrieved 2021-04-30.
  25. "Is Silicon Valley Arrogant? Not by My Definition". Bloomberg.com. 2013-11-08. Retrieved 2021-04-30.
  26. Giridharadas, Anand (2013-10-28). "Silicon Valley Roused by Secession Call". The New York Times. ISSN 0362-4331. Retrieved 2021-04-30.
  27. Manjoo, Farhad (2013-11-04). "Silicon Valley Has an Arrogance Problem". Wall Street Journal. ISSN 0099-9660. Retrieved 2021-04-30.
  28. Finley, Klint (23 November 2013). "Geeks for Monarchy: The Rise of the Neoreactionaries". TechCrunch.
  29. Cavaliere, Victoria (February 21, 2021) “Venture capitalist Balaji Srinivasan reportedly suggested doxxing a journalist who reported on narratives he didn't like.” Business Insider. (Retrieved April 21, 2021.)
  30. Metz, Cade (February 22, 2021) “Silicon Valley’s Safe Space.” New York Times. (Retrieved April 21, 2021.)
  31. Balakrishnan, Anita (2017-01-12). "Trump met with two Silicon Valley insiders who may join the FDA". CNBC. Retrieved 2021-04-29.
  32. Burton, Thomas M. (2017-01-13). "Donald Trump Looking Beyond Traditional Medical Experts for FDA Commissioner". Wall Street Journal. ISSN 0099-9660. Retrieved 2021-04-24.
  33. George, Varghese K. (2017-01-17). "Indian American could be FDA head under Trump". The Hindu. ISSN 0971-751X. Retrieved 2021-04-29.
  34. Langlois, Shawn. "The coronavirus will forever change us, according to an investor who was once eyed for Trump's top FDA gig". MarketWatch. Retrieved 2021-04-29.
  35. Burton, Thomas M. (2017-01-13). "Donald Trump Looking Beyond Traditional Medical Experts for FDA Commissioner". Wall Street Journal. ISSN 0099-9660. Retrieved 2021-04-29.
  36. RAJAGOPAL, DIVYA. "Balaji S Srinivasan may join Trump's team". The Economic Times. Retrieved 2021-04-30.
  37. Kafka, Peter (2017-01-14). "Balaji Srinivasan, who may run the FDA for Trump, hates the FDA. But Silicon Valley likes Srinivasan". Vox. Retrieved 2021-04-30.
  38. "Buterin, Srinivasan Donate to COVID Relief Fund for India 'Shaken' by Second Wave". finance.yahoo.com. Retrieved 2021-04-29.
  39. "Tech bosses pad up to help India in Covid fight; angel investor Balaji Srinivasan, Vinod Khosla, Sundar Pichai offer monetary support". The Economic Times. Retrieved 2021-04-29.
  40. "Why Ethereum's Vitalik Buterin, Tron's Justin Sun, Balaji Srinivasan Donated To India's Covid Relief". www.msn.com. Retrieved 2021-04-29.


This article "Balaji Srinivasan" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:Balaji Srinivasan. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.